Reference
Bolous NS, et al. The Cost-effectiveness of Gene Therapy for Severe Hemophilia B: Microsimulation Study from the United States Perspective. Blood : 25 Apr 2021. Available from: URL: http://doi.org/10.1182/blood.2021010864
Rights and permissions
About this article
Cite this article
AAV-FIX-Padua gene therapy cost effective for severe haemophilia B. PharmacoEcon Outcomes News 878, 1 (2021). https://doi.org/10.1007/s40274-021-7687-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7687-y